Stockreport

Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company"), a developer of psilocybin-based therapeutics, to [Read more]